Organic Baby Formula Recalled Following Botulism Cases

The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of infant botulism linked to Nara Organics Whole Milk Organic Powdered Infant Formula.

Three infants in California, Pennsylvania and Washington have been diagnosed with toxin type A infections after consuming formula in April or May.

Nara Organics Powd...

FDA Approves First Over-the-Counter Glucose Monitor for Children

The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children.

The continuous glucose monitor (CGM) — called the Stelo Glucose Biosensor System — is for use in children as young as 2 years old who do not use insulin.

This marks the first time a CG...

Many Patients Stop And Restart GLP-1 Meds, Study Finds

Folks are told that once you start taking Ozempic or Zepbound, you’ll need to stay on them to maintain the drugs’ benefits.

But patients prescribed such GLP-1 drugs are more likely to stop them and then restart use later than was previously assumed, according to research presented Sunday at the Endocrine Society’s annual ...

Trust In CDC Plummets Under Trump Administration, New Poll Shows

Public trust in the U.S. Centers for Disease Control and Prevention (CDC) has taken a nose dive under the Trump administration, a new poll has found.

Only 50% of U.S. adults now say they trust health recommendations issued by the CDC, compared to 77% in early 2025, according to a survey from Harvard T.H. Chan School of Public Health.

Half Of U.S. Parents Track Their Adult Children’s Location

Parents can track a child’s location at any moment through their kid’s smartphone, a feature meant to provide reassurance for anxious moms and dads.

But at what age should mom and dad stop the practice?  

A new poll finds half of U.S. parents (52%) saying they’ve continued to track the location of their 18-to-2...

Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting

Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure.

A new Northwestern Medicine study tracked more than 42,000 adults who started semaglutide, tirzepatide or liraglutide while taking multiple blood pressure drugs.

The authors tracked hypotensive episodes, including dizziness, fainting, fa...